AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 139 filers reported holding AMICUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,805 | -58.2% | 148,400 | -61.9% | 0.00% | -50.0% |
| Q1 2023 | $4,314 | -99.9% | 389,000 | +36.6% | 0.01% | +50.0% |
| Q3 2022 | $2,973,000 | +135.0% | 284,800 | +119.3% | 0.00% | +300.0% |
| Q4 2019 | $1,265,000 | -89.3% | 129,854 | -91.2% | 0.00% | -90.0% |
| Q3 2019 | $11,796,000 | +272.5% | 1,470,800 | +479.5% | 0.01% | +233.3% |
| Q2 2019 | $3,167,000 | +118.0% | 253,800 | +29.2% | 0.00% | 0.0% |
| Q3 2016 | $1,453,000 | -65.7% | 196,400 | -61.4% | 0.00% | -70.0% |
| Q4 2014 | $4,232,000 | +445.4% | 508,700 | +290.1% | 0.01% | +400.0% |
| Q3 2014 | $776,000 | +210.4% | 130,400 | +7.8% | 0.00% | +100.0% |
| Q1 2014 | $250,000 | -73.4% | 121,000 | -69.7% | 0.00% | -50.0% |
| Q4 2013 | $939,000 | +33.8% | 399,401 | +32.0% | 0.00% | 0.0% |
| Q3 2013 | $702,000 | +73.3% | 302,600 | +74.3% | 0.00% | +100.0% |
| Q2 2013 | $405,000 | – | 173,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |